Clinical Conversations: Myasthenia Gravis – A Practical Approach for GPs | Part two

Dr Fiona Chan

writer

Dr Fiona Chan

Neurologist; Specialising in Neuro-Ophthalmology and Neuro-Immunology

Dr Fiona Chan

 

This article about myasthenia gravis highlights the central role GPs have in the diagnosis and ongoing management of patients with this rare condition. This is part two of a three-part article.

This is part two of this series.
Read Part 1 >>
Read Part 3 >>

Practice points

• The acetylcholine (ACH) receptor antibody is the most common antibody found.

• MuSK” stands for “muscle-specific kinase” antibody and it targets the postsynaptic neuromuscular junction.

• In patients with generalised clinical myasthenia, approximately 85% of them have ACH receptor antibodies and about 5% to 10% of them have MuSK antibodies.

• If there are pure ocular symptoms, half the patients have ACH receptor antibodies but MuSK antibodies are very rare.

• If antibodies have returned positive and a patient is waiting for a clinic appointment, a CT chest is something easily ordered prior to the patient being referred.

• If the patient is starting to aspirate or has a high respiratory rate, shortness of breath, head drop or swallowing difficulties they should be referred to Emergency.

• Pyridostigmine (Mestinon®) works almost immediately but it is limited in its maximal benefit. Patients take it fifteen to thirty minutes before any activity and may self-titrate the dose.

• Plasma exchange that directly removes the pathological antibodies, and intravenous immunoglobulins are prescribed via the blood bank. Both are expensive and short-acting.

• Long-acting oral treatments include corticosteroids, azathioprine, methotrexate, mycophenolate, and the infusions, such as rituximab and cyclophosphamide, but the latter are chemotherapy drugs.

• Acute, high dose steroids can severely exacerbate myasthenia gravis symptoms and cause them to go into cholinergic crisis requiring intubation.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Efron

A/Prof Daryl Efron

Autism Spectrum Disorder in Children

Dr Sonia Davison

Dr Sonia Davison

Early Menopause

Scientia Prof Henry Brodaty AO

Scientia Prof Henry Brodaty AO

Donanemab – A GP Guide to Anti-Amyloid Therapies

Prof Andrew Sindone

Prof Andrew Sindone

LDL and Cardiovascular Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Fiona Chan

writer

Dr Fiona Chan

Neurologist; Specialising in Neuro-Ophthalmology and Neuro-Immunology

Test your knowledge

Recent articles

Latest GP poll

When do you plan to retire or leave general practice?

Within the next 12 months

0%

Within the next 3 years

0%

Within the next 5 years

0%

Within the next 10 years

0%

More than 10 years

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease